What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Her scientific interests lie mostly in Immunology, Internal medicine, Leukemia, Juvenile myelomonocytic leukemia and Oncology.
The concepts of her Immunology study are interwoven with issues in Hematopoietic stem cell transplantation, Transplantation, Germline mutation and Haematopoiesis, Bone marrow failure.
Her study on Internal medicine is mostly dedicated to connecting different topics, such as Surgery.
Her Leukemia research incorporates themes from Survival rate, Myeloid, Myeloid leukemia, Cytogenetics and Bone marrow.
Her Juvenile myelomonocytic leukemia study combines topics from a wide range of disciplines, such as Cancer research, Noonan syndrome, Myelodysplastic syndromes, PTPN11 and Chromosome 7.
Charlotte M. Niemeyer interconnects Myeloproliferative Disorders and NPM1 in the investigation of issues within Oncology.
Her most cited work include:
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia (786 citations)
- Germline KRAS mutations cause Noonan syndrome (593 citations)
- Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 (581 citations)
What are the main themes of her work throughout her whole career to date?
Charlotte M. Niemeyer focuses on Internal medicine, Immunology, Juvenile myelomonocytic leukemia, Cancer research and Leukemia.
Her Internal medicine research integrates issues from Gastroenterology and Oncology.
Her Gastroenterology study incorporates themes from Surgery and Chemotherapy.
The Immunology study combines topics in areas such as Haematopoiesis and Bone marrow failure.
Juvenile myelomonocytic leukemia is a primary field of her research addressed under Genetics.
Her Leukemia research incorporates elements of Myeloid and Myeloid leukemia.
She most often published in these fields:
- Internal medicine (30.63%)
- Immunology (30.02%)
- Juvenile myelomonocytic leukemia (27.59%)
What were the highlights of her more recent work (between 2015-2021)?
- Juvenile myelomonocytic leukemia (27.59%)
- Internal medicine (30.63%)
- Cancer research (21.10%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Juvenile myelomonocytic leukemia, Internal medicine, Cancer research, Hematopoietic stem cell transplantation and Immunology.
Her Internal medicine research includes themes of Gastroenterology and Oncology.
Her work deals with themes such as Haematopoiesis, Stem cell, KRAS, Leukemia and Epigenetics, which intersect with Cancer research.
Her research in Leukemia focuses on subjects like Myeloid, which are connected to Genetics.
Her study on Hematopoietic stem cell transplantation also encompasses disciplines like
- Monosomy that intertwine with fields like Germline mutation,
- Pediatrics and related Cytopenia,
- Diamond–Blackfan anemia which connect with Missense mutation.
Charlotte M. Niemeyer works on Immunology which deals in particular with Myelodysplastic syndromes.
Between 2015 and 2021, her most popular works were:
- The landscape of genomic alterations across childhood cancers (449 citations)
- The landscape of genomic alterations across childhood cancers (449 citations)
- Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. (166 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Charlotte M. Niemeyer spends much of her time researching Myelodysplastic syndromes, Cancer research, Leukemia, Juvenile myelomonocytic leukemia and Germline mutation.
Myelodysplastic syndromes is a subfield of Immunology that she studies.
Her Cancer research research is multidisciplinary, incorporating perspectives in KRAS, Haematopoiesis, Stem cell and Transplantation.
Leukemia is the subject of her research, which falls under Internal medicine.
Her Juvenile myelomonocytic leukemia research is multidisciplinary, relying on both Neuroblastoma RAS viral oncogene homolog, Intensive care medicine, DNA methylation and PTPN11.
Her Germline mutation research is classified as research in Genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
